Pittsburgh compound-B PET white matter imaging and cognitive function in late multiple sclerosisMultiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
Uses and risks of mitoxantine (Novantrone)Mitoxantrone is used to treat some types of multiple sclerosis (MS) and some types of cancer. It is given as an intravenous infusion in a clinical setting. Some serious...
Response to Vilariño-Güell et al.Multiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
What to know about itching and MSItching is one type of dysesthesia, or abnormal sensation, that occurs in people with multiple sclerosis. In this article, learn about why it occurs, as well as how...
Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59
Measurement of soluble CD59 in CSF in demyelinating disease: Evidence for an intrathecal source of soluble CD59Multiple Sclerosis Journal, Ahead of Print. … read morePosted At: MS Journal
- Next story Genetic study uncovers potential new treatments for inflammatory diseases
- Previous story Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
Join Our Mailing List
- Retinal degeneration is associated with brain volume reduction and prognosis in radiologically isolated syndrome
- False hepatitis B and C viral serologies in patients with multiple sclerosis receiving high-dose biotin
- What to know about marijuana and multiple sclerosis
- Using graphene to detect ALS, other neurodegenerative diseasesPosted At: Science Daily
- Is the ketogenic diet good for multiple sclerosis?
- What is Lhermitte’s sign?
- What to know about multiple sclerosis and mood swings
- FDA Issues Warning About Rare Risk of Stroke and Artery Wall Tears with Use of Lemtrada Posted At: National MS Society
- Pregnancy and multiple sclerosis in the DMT era: A cohort study in Western Austria
- Fatigue at enrollment predicts EDSS worsening in the New York State Multiple Sclerosis Consortium